(Q54345371)

28 May 2018

title

Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. (English)

1 reference

28 May 2018

0 references

3

1 reference

28 May 2018

author name string

Mastai R

1

1 reference

28 May 2018

Bosch J

2

1 reference

28 May 2018

Navasa M

4

1 reference

28 May 2018

Kravetz D

5

1 reference

28 May 2018

Rodés J

6

1 reference

28 May 2018

language of work or name

English

0 references

publication date

1 September 1989

1 reference

28 May 2018

published in

Hepatology

1 reference

28 May 2018

volume

10

1 reference

28 May 2018

issue

3

1 reference

28 May 2018

page(s)

269-272

1 reference

28 May 2018

Effects of Propranolol on Azygos Venous Blood Flow and Hepatic and Systemic Hemodynamics in Cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Effect of propranolol on hepatic and systemic hemodynamics in dogs with chronic bile duct ligation.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Splanchnic and hepatic metabolism of somatostatin: a study in cirrhotic patients with a portacaval shunt

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Propranolol for the prevention of recurrent variceal hemorrhage: a controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Local control of hepatic arterial and portal venous flow in the dog

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Effect of propranolol on hepatic blood flow in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840100302

7 January 2021

Identifiers

DOI

10.1002/HEP.1840100302

1 reference

28 May 2018

1 reference

28 May 2018